tiprankstipranks
SkinBioTherapeutics PLC (GB:SBTX)
LSE:SBTX
Holding GB:SBTX?
Track your performance easily

SkinBioTherapeutics (SBTX) Financial Statements

8 Followers

SkinBioTherapeutics Financial Overview

SkinBioTherapeutics's market cap is currently ―. The company's EPS TTM is p-0.016; its P/E ratio is -10.30; SkinBioTherapeutics is scheduled to report earnings on December 4, 2024, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Jun 22Dec 21Jun 21Dec 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments£ 765.98K£ 1.80M£ 3.15M£ 4.61M£ 5.48M
Total Assets£ 1.99M£ 3.08M£ 4.61M£ 5.73M£ 6.18M
Total Debt£ 109.51K£ 127.86K£ 127.57K£ 139.85K£ 0.00
Net Debt£ -656.47K£ -1.68M£ -3.03M£ -4.47M£ -5.48M
Total Liabilities£ 775.80K£ 609.61K£ 451.29K£ 519.67K£ 211.89K
Stockholders Equity£ 1.21M£ 2.48M£ 4.16M£ 5.22M£ 5.97M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in GBP

SkinBioTherapeutics Earnings and Revenue History

SkinBioTherapeutics Debt to Assets

SkinBioTherapeutics Cash Flow

SkinBioTherapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis